Linear immunoglobulin A bullous dermatosis

Clinics in Dermatology

Volumn 30, Issue 1, 2012, Pages 38-50

  Fortuna, Giulio ^a,b   Marinkovich, M Peter ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; COLCHICINE; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DICLOXACILLIN; ERYTHROMYCIN; FLUCLOXACILLIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; MIOKAMYCIN; MYCOPHENOLIC ACID; NICOTINAMIDE; OXACILLIN; PREDNISONE; SULFAMETHOXYPYRIDAZINE; SULFAPYRIDINE; TACROLIMUS;

ABDOMINAL PAIN; ACNE; ACUTE KIDNEY FAILURE; ADRENAL DISEASE; AGRANULOCYTOSIS; ALLERGIC PNEUMONITIS; AMENORRHEA; ANAPHYLAXIS; ANEMIA; ANOREXIA; APLASTIC ANEMIA; ARTHRALGIA; ARTICLE; ASEPTIC MENINGITIS; ASEPTIC NECROSIS; ASTHENIA; ATAXIA; BACKACHE; BASEMENT MEMBRANE; BLADDER DISEASE; BLADDER FIBROSIS; BLURRED VISION; BULLOUS SKIN DISEASE; CATARACT; CHILL; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; COLITIS; CONFUSION; CONGESTIVE HEART FAILURE; CONSTIPATION; CONVULSION; CUSHINGOID SYNDROME; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISTAL MOTOR NEUROPATHY; DIZZINESS; DRUG ERUPTION; DRUG RESPONSE; DYSESTHESIA; DYSPNEA; ECCHYMOSIS; ECZEMA; ELECTROLYTE DISTURBANCE; ERYTHEMA; ERYTHEMA MULTIFORME; FATIGUE; FEVER; FIBROSIS; FLUSHING; FOLLICULITIS; GINGIVA HYPERPLASIA; GLAUCOMA; GRANULOCYTOPENIA; GROWTH DISORDER; HAIR LOSS; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEMATURIA; HEMOLYSIS; HEMOLYTIC ANEMIA; HEMORRHAGIC COLITIS; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPOALBUMINEMIA; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; INSOMNIA; JAUNDICE; KIDNEY FAILURE; LARYNX EDEMA; LETHARGY; LEUKOPENIA; LINEAR IMMUNOGLOBULIN A BULLOUS DERMATOSIS; LIP DISEASE; LIVER FAILURE; LUNG FIBROSIS; LUPUS LIKE SYNDROME; METHEMOGLOBINEMIA; MONONUCLEOSIS; MOTOR NEUROPATHY; MUSCLE CRAMP; MYALGIA; NAUSEA; NEPHRITIS; NEPHROLITHIASIS; ONSET AGE; OSTEOPOROSIS; PAIN; PANCREATITIS; PARESTHESIA; PEPTIC ULCER; PERIPHERAL NEUROPATHY; PHARYNGITIS; PHLEBITIS; PRIORITY JOURNAL; PROTEINURIA; PRURITUS; RASH; REMISSION; SIDE EFFECT; SKIN BURNING SENSATION; STEVENS JOHNSON SYNDROME; SWELLING; TACHYCARDIA; THORAX PAIN; THROMBOCYTOPENIA; TONGUE DISEASE; TOXIC EPIDERMAL NECROLYSIS; TOXIC HEPATITIS; TREMOR; URTICARIA; VERTIGO; VOMITING; WOUND HEALING IMPAIRMENT;

ADULT; AGE OF ONSET; ANTI-INFECTIVE AGENTS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; CHILD; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN A; SKIN DISEASES, VESICULOBULLOUS;

EID: 83155190188     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.03.008     Document Type: Article

References (152)

1. Bowen J.T. Six cases of bullous dermatitis following vaccination, and resembling dermatitis herpetiformis. J Cutan Dis 1901, 19:401-423.
2. Bowen J.T. Dermatitis herpetiformis in children. J Cutan Dis 1905, 23:381-401.
3. Kim R., Winkelmann R.K. Dermatitis herpetiformis in children. Relationship to bullous pemphigoid. Arch Dermatol 1961, 83:895-902.
4. Jordon R.E., Bean S.F., Triftshauser C.T., et al. Childhood bullous dermatitis herpetiformis. Negative immunofluorescent tests. Arch Dermatol 1970, 101:629-634.
5. Tolman M.M., Moschella S.L., Schneiderman R.N. Dermatitis herpetiformis; specific entity or clinical complex. J Invest Dermatol 1959, 32:557-561.
6. Honeyman J.F., Honeyman A., Lobitz W.C., et al. The enigma of bullous pemphigoid and dermatitis herpetiformis. Arch Dermatol 1972, 106:22-25.
7. Jablonska S., Chorzelski T.P., Beutner E.H., et al. Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms. Arch Dermatol 1976, 112:45-48.
8. Chorzelski T.P., Jablonska S. IgA linear dermatosis of childhood (chronic bullous disease of childhood). Br J Dermatol 1979, 101:535-542.
9. Pothupitiya G.M., Wojnarowska F., Bhogal B.S., et al. Distribution of the antigen in adult linear IgA disease and chronic bullous dermatosis of childhood suggests that it is a single and unique antigen. Br J Dermatol 1988, 118:175-182.
10. Zone J.J., Taylor T.B., Kadunce D.P., et al. IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein. J Invest Dermatol 1996, 106:1277-1280.
11. Guide S.V., Marinkovich M.P. Linear IgA bullous dermatosis. Clin Dermatol 2001, 19:719-727.
12. Lee S.Y., Leung C.Y., Leung C.W., et al. Linear IgA bullous dermatosis in a neonate. Arch Dis Child Fetal Neonatal Ed 2004, 89:F280.
13. Gluth M.B., Witman P.M., Thompson D.M. Upper aerodigestive tract complications in a neonate with linear IgA bullous dermatosis. Int J Pediatr Otorhinolaryngol 2004, 68:965-970.
14. Nanda A., Dvorak R., Al-Sabah H., et al. Linear IgA bullous disease of childhood: an experience from Kuwait. Pediatr Dermatol 2006, 23:443-447.
15. Nanda A., Dvorak R., Al-Saeed K., et al. Spectrum of autoimmune bullous diseases in Kuwait. Int J Dermatol 2004, 43:876-881.
16. Kenani N., Mebazaa A., Denguezli M., et al. Childhood linear IgA bullous dermatosis in Tunisia. Pediatr Dermatol 2009, 26:28-33.
17. Aboobaker J., Wojnarowska F.T., Bhogal B., et al. Chronic bullous dermatosis of childhood-clinical and immunological features seen in African patients. Clin Exp Dermatol 1991, 16:160-164.
18. Mulyowa G.K., Jaeger G., Kabakyenga J., et al. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients. Int J Dermatol 2006, 45:1047-1052.
19. Kanwar A.J., Sandhu K., Handa S. Chronic bullous dermatosis of childhood in north India. Pediatr Dermatol 2004, 21:610-612.
20. Ratnam K.V., Lee C.T., Tan T. Chronic bullous dermatosis of childhood in Singapore. Int J Dermatol 1986, 25:34-37.
21. Jin P., Shao C., Ye G. Chronic bullous dermatoses in China. Int J Dermatol 1993, 32:89-92.
22. Horiguchi Y., Ikoma A., Sakai R., et al. Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan. J Dermatol 2008, 35:737-743.
23. Klein PA, Callen JP Linear IgA dermatosis Available at:, (updated: Sep 28, 2010) Accessed: April 20, 2011. http://emedicine.medscape.com/article/1063590-overview.
24. Zillikens D., Wever S., Roth A., et al. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995, 131:957-958.
25. Bertram F., Brocker E.B., Zillikens D., et al. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009, 7:434-440.
26. Bernard P., Vaillant L., Labeille B., et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions Bullous Diseases French Study Group. Arch Dermatol 1995, 131:48-52.
27. Wong S.N., Chua S.H. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol 2002, 147:476-480.
28. Burge S., Wojnarowska F., Marsden A. Chronic bullous dermatosis of childhood persisting into adulthood. Pediatr Dermatol 1988, 5:246-249.
29. Talhari C., Althaus C., Megahed M. Ocular linear IgA disease resulting in blindness. Arch Dermatol 2006, 142:786-787.
30. Sato K., Hanazawa H., Sato Y., et al. Initial presentation and fatal complications of linear IgA bullous dermatosis in the larynx and pharynx. J Laryngol Otol 2005, 119:314-318.
31. Marsden R.A., McKee P.H., Bhogal B., et al. A study of benign chronic bullous dermatosis of childhood and comparison with dermatitis herpetiformis and bullous pemphigoid occurring in childhood. Clin Exp Dermatol 1980, 5:159-176.
32. Edwards S., Wojnarowska F. Chronic bullous disease of childhood in three patients of Polynesian extraction. Clin Exp Dermatol 1990, 15:367-369.
33. Hashimoto K., Miki Y., Nishioka K., et al. HLA antigens in dermatitis herpetiformis among Japanese. J Dermatol 1980, 7:289-291.
34. Ratnam K.V. IgA dermatosis in an adult Chinese population. A 10-year study of linear IgA and dermatitis herpetiformis in Singapore. Int J Dermatol 1988, 27:21-24.
35. Collier P.M., Wojnarowska F., Welsh K., et al. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol 1999, 141:867-875.
36. Zhou S., Ferguson D.J., Allen J., et al. The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting. Br J Dermatol 1998, 139:591-597.
37. Allen J., Phan T.T., Hughes M.A., et al. The cellular origins of the linear IgA disease target antigens: an indirect immunofluorescence study using cultured human keratinocytes and fibroblasts. Br J Dermatol 2003, 148:945-953.
38. Allen J., Wojnarowska F. Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein. Br J Dermatol 2003, 149:1055-1058.
39. Metz B.J., Ruggeri S.Y., Hsu S., et al. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype. Int J Dermatol 2004, 43:443-446.
40. Leonard J.N., Haffenden G.P., Unsworth D.J., et al. Evidence that the IgA in patients with linear IgA disease is qualitatively different from that of patients with dermatitis herpetiformis. Br J Dermatol 1984, 110:315-321.
41. deFranchis R., Primignani M., Cipolla M., et al. Small-bowel involvement in dermatitis herpetiformis and in linear-IgA bullous dermatosis. J Clin Gastroenterol 1983, 5:429-436.
42. Rusenko K.W., Gammon W.R., Briggaman R.A., Type V.I.I. collagen is the antigen recognized by IgA anti-sub lamina densa autoantibodies. J Invest Dermatol 1989, 92:510. (abstract).
43. Zone J.J., Taylor T.B., Kadunce D.P., et al. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. J Clin Invest 1990, 85:812-820.
44. Wojnarowska F., Whitehead P., Leigh I.M., et al. Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. Br J Dermatol 1991, 124:157-162.
45. Dmochowski M., Hashimoto T., Bhogal B.S., et al. Immunoblotting studies of linear IgA disease. J Dermatol Sci 1993, 6:194-200.
46. Kanitakis J., Mauduit G., Cozzani E., et al. Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen. Pediatr Dermatol 1994, 11:139-144.
47. Zambruno G., Manca V., Kanitakis J., et al. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 1994, 31:884-888.
48. Collier P., Wojnarowska F., Allen J., et al. Molecular overlap of the IgA target antigens in the subepidermal blistering diseases. Dermatology 1994, 189(suppl 1):105-107.
49. Yamane Y., Sato H., Higashi K., et al. Linear immunoglobulin A (IgA) bullous dermatosis of childhood: identification of the target antigens and study of the cellular sources. Br J Dermatol 1996, 135:785-790.
50. Marinkovich M.P., Taylor T.B., Keene D.R., et al. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol 1996, 106:734-738.
51. Allen J., Zhou S., Wakelin S.H., et al. Linear IgA disease: a report of two dermal binding sera which recognize a pepsin-sensitive epitope (?NC-1 domain) of collagen type VII. Br J Dermatol 1997, 137:526-533.
52. Fujimoto W., Ohtsu T., Toi Y., et al. Linear IgA disease with IgA antibodies directed against 200- and 280-kDa epidermal antigens. Br J Dermatol 2000, 142:1213-1218.
53. Allen J., Wojnarowska F. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults. Br J Dermatol 2003, 149:977-985.
54. Wojnarowska F., Bhogal B.S., Black M.M. Chronic bullous disease of childhood and linear IgA disease of adults are IgA1-mediated diseases. Br J Dermatol 1994, 131:201-204.
55. Egan C.A., Martineau M.R., Taylor T.B., et al. IgA antibodies recognizing LABD97 are predominantly IgA1 subclass. Acta Derm Venereol 1999, 79:343-346.
56. Hirako Y., Usukura J., Uematsu J., et al. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem 1998, 273:9711-9717.
57. Zone J.J., Taylor T.B., Meyer L.J., et al. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 1998, 110:207-210.
58. Marinkovich M.P., Tran H.H., Rao S.K., et al. LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. J Invest Dermatol 1997, 109:356-359.
59. Ishiko A., Shimizu H., Masunaga T., et al. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen. J Invest Dermatol 1998, 111:93-96.
60. Vodegel R.M., de Jong M.C., Pas H.H., et al. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 2002, 47:919-925.
61. Georgi M., Scheckenbach C., Kromminga A., et al. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease. Arch Dermatol Res 2001, 293:109-114.
62. Zillikens D., Herzele K., Georgi M., et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol 1999, 113:947-953.
63. Lin M.S., Fu C.L., Olague-Marchan M., et al. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Clin Immunol 2002, 102:310-319.
64. Caproni M., Rolfo S., Bernacchi E., et al. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis. Br J Dermatol 1999, 140:1072-1078.
65. Young H.S., Coulson I.H. Linear IgA disease: successful treatment with cyclosporin. Br J Dermatol 2000, 143:204-205.
66. Benbenisty K.M., Bowman P.H., Davis L.S. Localized linear IgA disease responding to colchicine. Int J Dermatol 2002, 41:56-58.
67. Smith J.R., Kupa A., Coster D.J. Linear IgA disease. Aust N Z J Ophthalmol 1999, 27:443-446.
68. Zone J.J., Egan C.A., Taylor T.B., et al. IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004, 9:47-51.
69. Okayama Y., Kawakami T. Development, migration, and survival of mast cells. Immunol Res 2006, 34:97-115.
70. Shelburne C.P., Ryan J.J. The role of Th2 cytokines in mast cell homeostasis. Immunol Rev 2001, 179:82-93.
71. Moller A., Lippert U., Lessmann D., et al. Human mast cells produce IL-8. J Immunol 1993, 151:3261-3266.
72. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741.
73. Kouro T., Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol 2009, 21:1303-1309.
74. Yancey K.B. The pathophysiology of autoimmune blistering diseases. J Clin Invest 2005, 115:825-828.
75. Liu Z., Li N., Diaz L.A., et al. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J Clin Invest 2005, 115:879-887.
76. Hofmann S.C., Voith U., Schonau V., et al. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97. J Invest Dermatol 2009, 129:1730-1739.
77. Jensen P.J., Baird J., Morioka S., et al. Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 1988, 90:777-782.
78. Baird J., Lazarus G.S., Belin D., et al. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 1990, 95:548-552.
79. Liu Z., Zhou X., Shapiro S.D., et al. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 2000, 102:647-655.
80. Banda M.J., Rice A.G., Griffin G.L., et al. The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant. J Exp Med 1988, 167:1608-1615.
81. Egan C.A., Zone J.J. Linear IgA bullous dermatosis. Int J Dermatol 1999, 38:818-827.
82. Patricio P., Ferreira C., Gomes M.M., et al. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci 2009, 1173:203-210.
83. Weinberg M.A., Insler M.S., Campen R.B. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 84:517-534.
84. Torchia D., Caproni M., Del Bianco E., et al. Linear IgA disease presenting as prurigo nodularis. Br J Dermatol 2006, 155:479-480.
85. Yoneda K., Yokoi I., Demitsu T., et al. Localized linear IgA disease showing contact dermatitis-like eruption. Eur J Dermatol 2007, 17:339-340.
86. Fuligni A., Di Blasi A., Borgogni L., et al. A peculiar case of linear IgA bullous dermatosis. Arch Dermatol 1991, 127:126-127.
87. Kelly S.E., Frith P.A., Millard P.R., et al. A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 1988, 119:161-170.
88. Eguia del Valle A., Aguirre Urizar J.M., Martinez Sahuquillo A. Oral manifestations caused by the linear IgA disease. Med Oral 2004, 9:39-44.
89. Chan L.S., Regezi J.A., Cooper K.D. Oral manifestations of linear IgA disease. J Am Acad Dermatol 1990, 22:362-365.
90. Edwards S., Wojnarowska F., Armstrong L.M. Chronic bullous disease of childhood with oral mucosal scarring. Clin Exp Dermatol 1991, 16:41-43.
91. O'Regan E., Bane A., Flint S., et al. Linear IgA disease presenting as desquamative gingivitis: a pattern poorly recognized in medicine. Arch Otolaryngol Head Neck Surg 2004, 130:469-472.
92. Torchia D., Caproni M., Fabbri P. Linear IgA disease and desquamative gingivitis: time for inclusion in mucous membrane pemphigoid. Oral Dis 2008, 14:768-769. author reply 70.
93. del Valle A.E., Martinez-Sahuquillo A., Padron J.R., et al. Two cases of linear IgA disease with clinical manifestations limited to the gingiva. J Periodontol 2003, 74:879-882.
94. Aultbrinker E.A., Starr M.B., Donnenfeld E.D. Linear IgA disease. The ocular manifestations. Ophthalmology 1988, 95:340-343.
95. Letko E., Bhol K., Foster C.S., et al. Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy. Ophthalmology 2000, 107:1524-1528.
96. Verhelst F., Demedts M., Verschakelen J., et al. Adult linear IgA bullous dermatosis with bronchial involvement. Br J Dermatol 1987, 116:587-590.
97. Chan L.S., Traczyk T., Taylor T.B., et al. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol 1995, 131:1432-1437.
98. Kirtschig G., Mengel R., Mittag H., et al. Desquamative gingivitis and balanitis-linear IgA disease or cicatricial pemphigoid?. Clin Exp Dermatol 1998, 23:173-177.
99. Girao L., Fiadeiro T., Rodrigues J.C. Burn-induced linear IgA dermatosis. J Eur Acad Dermatol Venereol 2000, 14:507-510.
100. He C., Xu H., Xiao T., et al. Localized linear IgA dermatosis induced by UV light-treatment for herpes zoster. Int J Dermatol 2007, 46:500-502.
101. Collier P.M., Kelly S.E., Wojnarowska F. Linear IgA disease and pregnancy. J Am Acad Dermatol 1994, 30:407-411.
102. Camilleri M., Pace J.L. Drug-induced linear immunoglobulin-A bullous dermatosis. Clin Dermatol 1998, 16:389-391.
103. Baden L.A., Apovian C., Imber M.J., et al. Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 1988, 124:1186-1188.
104. Primka E., Gay D., Bergfeld W. Drug-induced linear IgA disease (histopathologic features of three cases). J Cutan Pathol 1996, 23:58. (abstract).
105. Klein P.A., Callen J.P. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency. J Am Acad Dermatol 2000, 42:316-323.
106. Palmer R.A., Ogg G., Allen J., et al. Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol 2001, 145:816-820.
107. Joshi S., Scott G., Looney R.J. A successful challenge in a patient with vancomycin-induced linear IgA dermatosis. Ann Allergy Asthma Immunol 2004, 93:101-103.
108. Eisendle K., Bonatti H., Sepp N., et al. Vancomycin-induced linear IgA bullous dermatosis in an immunosuppressed transplant recipient. J Eur Acad Dermatol Venereol 2007, 21:996-997.
109. Billet S.E., Kortuem K.R., Gibson L.E., et al. A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 2008, 144:774-778.
110. Walsh S.N., Kerchner K., Sangueza O.P. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels. Arch Dermatol 2009, 145:603-604.
111. McDonald H.C., York N.R., Pandya A.G. Drug-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon. J Am Acad Dermatol 2010, 62:897-898.
112. Paul C., Wolkenstein P., Prost C., et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol 1997, 136:406-411.
113. Friedman I.S., Rudikoff D., Phelps R.G., et al. Captopril-triggered linear IgA bullous dermatosis. Int J Dermatol 1998, 37:608-612.
114. Yawalkar N., Reimers A., Hari Y., et al. Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells. Dermatology 1999, 199:25-30.
115. Bouldin M.B., Clowers-Webb H.E., Davis J.L., et al. Naproxen-associated linear IgA bullous dermatosis: case report and review. Mayo Clin Proc 2000, 75:967-970.
116. Plunkett R.W., Chiarello S.E., Beutner E.H. Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature. J Am Acad Dermatol 2001, 45:691-696.
117. Khan I., Hughes R., Curran S., et al. Drug-associated linear IgA disease mimicking toxic epidermal necrolysis. Clin Exp Dermatol 2009, 34:715-717.
118. Jouan N., Plantin P., Berthou C., et al. [Association of IgA linear dermatitis and non-Hodgkin's malignant lymphoma]. Rev Med Interne 1992, 13:153-155.
119. Kapur A., Isaacs P.E., Kelsey P.R. Linear IgA dermatosis, coeliac disease, and extraintestinal B cell lymphoma. Gut 1995, 37:731-733.
120. Usmani N., Baxter K.F., Child J.A., et al. Linear IgA disease in association with chronic lymphocytic leukaemia. Br J Dermatol 2004, 151:710-711.
121. Rodenas J.M., Herranz M.T., Tercedor J., et al. Linear IgA disease in a patient with bladder carcinoma. Br J Dermatol 1997, 136:257-259.
122. Walker S.L., Banerjee P., Harland C.C., et al. Remission of linear IgA disease associated with ulcerative colitis following panproclocolectomy. Br J Dermatol 2000, 143:1341-1342.
123. Tobon G.J., Toro C.E., Bravo J.C., et al. Linear IgA bullous dermatosis associated with systemic lupus erythematosus: a case report. Clin Rheumatol 2008, 27:391-393.
124. Jablonska S., Chorzelski T.P., Rosinska D., et al. Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood). Clin Dermatol 1991, 9:393-401.
125. Van L., Browning J.C., Krishnan R.S., et al. Dermatitis herpetiformis: potential for confusion with linear IgA bullous dermatosis on direct immunofluorescence. Dermatol Online J 2008, 14:21.
126. Wojnarowska F., Marsden R.A., Bhogal B., et al. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988, 19:792-805.
127. Gammon W.R., Briggaman R.A., Inman A.O., et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984, 82:139-144.
128. Lally A., Chamberlain A., Allen J., et al. Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease. Clin Exp Dermatol 2007, 32:493-498.
129. Willsteed E., Bhogal B.S., Black M.M., et al. Use of 1M NaCl split skin in the indirect immunofluorescence of the linear IgA bullous dermatoses. J Cutan Pathol 1990, 17:144-148.
130. Wojnarowska F., Collier P.M., Allen J., et al. The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used. Br J Dermatol 1995, 132:750-757.
131. Dabrowski J., Chorzelski T., Jablonska S., et al. Immunoelectron microscopic studies in IgA linear dermatosis. Arch Dermatol Res 1979, 265:289-298.
132. Prost C., De Leca A.C., Combemale P., et al. Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. J Invest Dermatol 1989, 92:39-45.
133. Bhogal B., Wojnarowska F., Marsden R.A., et al. Linear IgA bullous dermatosis of adults and children: an immunoelectron microscopic study. Br J Dermatol 1987, 117:289-296.
134. Adachi A., Tani M., Matsubayashi S., et al. Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid. J Am Acad Dermatol 1992, 27:394-399.
135. Wojnarowska F. Linear IgA dapsone responsive bullous dermatosis. J R Soc Med 1980, 73:371-373.
136. Jablonska S. The therapies for linear IgA bullous dermatosis of childhood. Pediatr Dermatol 1999, 16:415.
137. Khanna N., Pandhi R.K., Gupta S., et al. Response of chronic bullous dermatosis of childhood to a combination of dapsone and nicotinamide. J Eur Acad Dermatol Venereol 2001, 15:368.
138. Pulimood S., Ajithkumar K., Jacob M., et al. Linear IgA bullous dermatosis of childhood: treatment with dapsone and co-trimoxazole. Clin Exp Dermatol 1997, 22:90-91.
139. Schiffner J.H. Therapy of childhood linear IgA dermatitis herpetiformis. J Am Acad Dermatol 1982, 6:403-404.
140. McFadden J.P., Leonard J.N., Powles A.V., et al. Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989, 121:759-762.
141. Farley-Li J., Mancini A.J. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol 2003, 139:1121-1124.
142. Ang P., Tay Y.K. Treatment of linear IgA bullous dermatosis of childhood with colchicine. Pediatr Dermatol 1999, 16:50-52.
143. Dauendorffer J.N., Mahe E., Saiag P. Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol 2008, 22:364-365.
144. Denguezli M., Ben Nejma B., Nouira R., et al. [Iga linear bullous dermatosis in children. A series of 12 Tunisian patients]. Ann Dermatol Venereol 1994, 121:888-892.
145. Siegfried E.C., Sirawan S. Chronic bullous disease of childhood: successful treatment with dicloxacillin. J Am Acad Dermatol 1998, 39:797-800.
146. Cooper S.M., Powell J., Wojnarowska F. Linear IgA disease: successful treatment with erythromycin. Clin Exp Dermatol 2002, 27:677-679.
147. Alajlan A., Al-Khawajah M., Al-Sheikh O., et al. Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin. J Am Acad Dermatol 2006, 54:652-656.
148. Peterson J.D., Chan L.S. Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole. Clin Exp Dermatol 2007, 32:756-758.
149. Mervic L., Dragos V., Pavlovic M.D. Linear IgA bullous dermatosis of childhood: successful treatment with miocamycin and topical corticosteroid. Clin Exp Dermatol 2009, 34:e391-2.
150. Kroiss M.M., Vogt T., Landthaler M., et al. High-dose intravenous immune globulin is also effective in linear IgA disease. Br J Dermatol 2000, 142:582.
151. Kasperkiewicz M., Meier M., Zillikens D., et al. Linear IgA disease: successful application of immunoadsorption and review of the literature. Dermatology 2010, 220:259-263.
152. Billet S.E., Grando S.A., Pittelkow M.R. Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006, 39:617-630.